Mark J. Ratain to Genetic Therapy
This is a "connection" page, showing publications Mark J. Ratain has written about Genetic Therapy.
Connection Strength
0.954
-
An Ethical and Financial Obligation for Sickle Cell Disease Gene Therapy in the United States. Ann Intern Med. 2024 01; 177(1):85-86.
Score: 0.753
-
Delivery of a liposomal c-raf-1 antisense oligonucleotide by weekly bolus dosing in patients with advanced solid tumors: a phase I study. Clin Cancer Res. 2004 Nov 01; 10(21):7244-51.
Score: 0.201